DOMZOL-SR is a sustained-release corticosteroid medication formulated with deflazacort, primarily used to treat inflammation, severe allergic reactions, and immune-related disorders. As a potent anti-inflammatory and immunosuppressive agent, DOMZOL-SR is effective in managing a range of conditions, from chronic inflammatory diseases to acute flare-ups of autoimmune conditions. It is particularly beneficial for patients requiring extended relief from inflammation and immune response regulation.
Deflazacort: Deflazacort is a corticosteroid that works by reducing inflammation and modulating the immune system. It inhibits the release of certain chemicals in the body responsible for inflammatory responses, making it highly effective for treating conditions requiring immune suppression or inflammation control. Deflazacort is known for its favorable side-effect profile compared to other corticosteroids, offering patients effective management with potentially lower risk of adverse effects.
Reduces inflammation: DOMZOL-SR provides rapid and sustained relief from inflammation, making it ideal for conditions such as arthritis, inflammatory bowel disease, and other chronic inflammatory disorders.
Suppresses immune response: Its immunosuppressive action helps manage autoimmune conditions by lowering overactive immune responses, providing relief in conditions like rheumatoid arthritis, lupus, and severe allergic reactions.
Long-lasting relief: The sustained-release formulation of DOMZOL-SR ensures consistent therapeutic effects over time, reducing the need for frequent dosing and supporting better patient adherence.
Versatile treatment: DOMZOL-SR can also help manage acute flare-ups of chronic conditions, making it a versatile choice for both long-term treatment and immediate symptom relief.
While DOMZOL-SR is generally well-tolerated, it is essential to follow medical advice carefully when using corticosteroids. Possible side effects may include weight gain, mood changes, increased blood pressure, and changes in blood sugar levels. Long-term use of corticosteroids may lead to additional side effects, such as osteoporosis or weakened immunity. DOMZOL-SR is not recommended for individuals with known hypersensitivity to deflazacort or other corticosteroids, and it should be used cautiously in patients with liver, kidney, or cardiovascular conditions. Always consult your healthcare provider before starting or adjusting your dosage, especially if taking other medications, to avoid potential interactions.
DOMZOL-SR by Medicox Life Science provides reliable and controlled management of inflammation and immune response, offering patients a potent yet well-tolerated option for chronic and acute inflammatory conditions. The sustained-release formulation ensures long-lasting relief, reducing the need for multiple doses and supporting ease of use. Medicox Life Science’s commitment to quality and patient safety ensures that each dose of DOMZOL-SR is manufactured to the highest standards, providing consistent and effective care for those managing complex inflammatory and autoimmune conditions.
Acid reflux and heartburn can be tough, but our PPIs and antacids provide fast, reliable relief. Perfect for expanding your business, these products offer proven solutions that people can trust, making them ideal for our PCD Pharma partners.
Join as a partner, dealer, or distributor to deliver quality healthcare solutions across India.
Get in Touch